Vaxzevria [COVID-19 Vaccine AstraZeneca]

Medicinal product

(Invented) name

Active substance (s)

COVID-19 vakcina (ChAdOx1-S vakcina (rekombinantinė)). ChAdOx1-S SARS-CoV-2

Strength

2,5 × 10(8) inf. V

Pharmaceutical form

injekcinė suspensija

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J07BN02, covid-19, viral vector, non-replicating

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2021-01-29

Date of renewal

Documents

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Suspension for injection. One dose (0.5 ml) contains not less than:	0.5 ml
COVID-19 vakcina (ChAdOx1-S vakcina (rekombinantinė)). ChAdOx1-S SARS-CoV-2	2,5 × 10(8) inf. V

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105688	91788	1091788	flakonas	N10 (daugiadozis, 100 dozių)		Receptinis	EU/1/21/1529/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-05-07	Išregistruotas
2021-01-29	Registruotas